In obese mice, FNDC5/irisin improves insulin resistance, corrects glucose and lipid metabolic abnormalities, and enhances lipolysis via the cAMP-PKA-HSL/perilipin pathway (Xiong et al., 2015). The gene discussed is FNDC5; the disease is Insulin resistance.